Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019
For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years liv...
Saved in:
Published in | BMC public health Vol. 23; no. 1; pp. 582 - 13 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
29.03.2023
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.
The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated.
Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels.
GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates. |
---|---|
AbstractList | Introduction For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. Methods The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated. Results Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels. Conclusion GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates. Keywords: Gastro-esophageal reflux disease, Global burden disease, Age-standardized rate, Epidemiology For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.INTRODUCTIONFor effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated.METHODSThe burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated.Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels.RESULTSData to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels.GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates.CONCLUSIONGORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates. For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated. Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels. GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates. IntroductionFor effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.MethodsThe burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated.ResultsData to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels.ConclusionGORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates. Abstract Introduction For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. Methods The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated. Results Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels. Conclusion GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates. For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. The burden of GORD between 1990 and 2019 was evaluated globally, regionally, and nationally. Using ASIR (age-standardized incidence), ASYLDs (age-standardized years lived with disabilitys), we compared them to the GBD world population per 100,000. The estimates were based on 95% uncertainty intervals (UIs). The AAPC (average annual percent change) in incidence, YLDs, along with prevalence rates with associated 95% CIs were estimated. Data to estimate the burden of GORD are scarce till now. The global ASIR of GORD in 2019 was 3792.79 per 100,000, an increase AAPC of 0.112% from 1990. The prevalence of GORD increased with a AAPC of 0.096% to 9574.45 per 100,000. Global ASYLDs in 2019 was 73.63, an increase AAPC of 0.105% from 1990. The GORD burden varies greatly depending on the development level and geographical location. USA demonstrated the most obvious decreasing trend in burden of GORD, while Sweden had an increasing trend. That the increase in GORD YLDs was mediated primarily by the growth and aging of population, was revealed by decomposition analyses. There was an inverse relationship between SDI (socio-demographic index) and GORD-burden. Frontier analyses revealed significant scope of improvement in the status of development at all levels. GORD is a public health challenge, especially in Latin America. Some SDI quintiles had declining rates, while some countries experienced increased rates. Thus, resources should be allocated for preventative measures based on country-specific estimates. |
ArticleNumber | 582 |
Audience | Academic |
Author | Yang, Wan-Li Xue, Li-Wei Zhao, Ran Cai, Mei-Hong Yan, Xia-Lin Li, Meng-Ting Li, Na Tang, Ming-Yu Hong, Liu Chen, Xiang |
Author_xml | – sequence: 1 givenname: Na surname: Li fullname: Li, Na – sequence: 2 givenname: Wan-Li surname: Yang fullname: Yang, Wan-Li – sequence: 3 givenname: Mei-Hong surname: Cai fullname: Cai, Mei-Hong – sequence: 4 givenname: Xiang surname: Chen fullname: Chen, Xiang – sequence: 5 givenname: Ran surname: Zhao fullname: Zhao, Ran – sequence: 6 givenname: Meng-Ting surname: Li fullname: Li, Meng-Ting – sequence: 7 givenname: Xia-Lin surname: Yan fullname: Yan, Xia-Lin – sequence: 8 givenname: Li-Wei surname: Xue fullname: Xue, Li-Wei – sequence: 9 givenname: Liu surname: Hong fullname: Hong, Liu – sequence: 10 givenname: Ming-Yu surname: Tang fullname: Tang, Ming-Yu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36978027$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1u1DAUhSNURH_gBVggS2xYkGI7TuywqUoFpVIlNrC2HPt6xqNMXOwEMV3xDux4PJ6Em05Lf4RQFkluzv1OjnX2i50hDlAUzxk9ZEw1bzLjSrUl5VXJai55efmo2GNCspKLWu3ced4t9nNeUcqkqvmTYrdqWqkol3vFr3dTcjCQ6MnC5DFFyPFiaRZgepLA99N34kIGk4GEgXAqiI3TMKYAmZjBkRFSCmOc318T1rb094-fnLL2LTEkb_IIazMGi1LTb3LIxMdExiWQ0z52aHHrfuOSx8ltyIx4Wjz2ps_w7Pp-UHz58P7zycfy_NPp2cnxeWnrRowlOKDSUO-ZAtqqqlaisR7DNYBjZY2TDZeCNR3r6roBL1ktfcfqzjUOVdVBcbblumhW-iKFtUkbHU3QV4OYFtokDNGD5s7Mm8Zb3glbi05W1Eo0Fa2tVCuRdbRlXUzdGpwFPCrT34Pe_zKEpV7Eb5pRWlf4n0h4dU1I8esEedTrkC30vRkgTllz2fKaci4qlL58IF3FKeFJo0rRConYklvVwmCCMPiIxnaG6mMpKiFaXs22h_9Q4eVgHSz2zgec31t4cTfp34g31UKB2gpsijljl7QNI5YhzsFDj4n13GK9bbHGFuurFutLXOUPVm_o_1n6A5BF884 |
CitedBy_id | crossref_primary_10_1088_2057_1976_ad5a14 crossref_primary_10_1016_j_clnesp_2024_11_028 crossref_primary_10_31146_1682_8658_ecg_218_10_77_87 crossref_primary_10_32388_LJ6FPN crossref_primary_10_7759_cureus_60814 crossref_primary_10_1007_s10620_024_08765_3 crossref_primary_10_7704_kjhugr_2024_0020 crossref_primary_10_1097_MOG_0000000000001082 crossref_primary_10_1111_nmo_14969 crossref_primary_10_1111_apt_18458 crossref_primary_10_7759_cureus_50840 crossref_primary_10_3390_diagnostics13243602 crossref_primary_10_3390_medicina59071270 crossref_primary_10_21518_ms2024_039 crossref_primary_10_3390_nu16162779 crossref_primary_10_1186_s12903_025_05516_2 crossref_primary_10_1097_01_JAA_0001005620_54669_f4 crossref_primary_10_2147_JMDH_S485781 crossref_primary_10_3390_s23218858 crossref_primary_10_1021_acsami_3c13825 crossref_primary_10_3390_healthcare11192637 crossref_primary_10_4253_wjge_v17_i1_100219 crossref_primary_10_3390_ijerph21121696 crossref_primary_10_1016_j_resinv_2024_08_007 crossref_primary_10_1371_journal_pone_0306223 crossref_primary_10_3389_fimmu_2025_1420132 crossref_primary_10_1111_ppe_13156 crossref_primary_10_3389_fmed_2024_1346888 crossref_primary_10_3748_wjg_v31_i4_101933 crossref_primary_10_1007_s00394_024_03491_y crossref_primary_10_1097_MD_0000000000039248 crossref_primary_10_12677_acm_2025_152395 crossref_primary_10_1155_2024_9990554 crossref_primary_10_21518_ms2024_546 crossref_primary_10_1007_s10620_024_08290_3 |
Cites_doi | 10.1016/j.ejim.2015.05.005 10.1001/jamaoncol.2019.2996 10.1002/alr.22259 10.1016/S0140-6736(20)30925-9 10.3109/00365520903428606 10.1016/S0140-6736(06)68932-0 10.1038/s41572-021-00287-w 10.2174/1874306401206010121 10.1016/j.bpg.2017.09.004 10.1136/gutjnl-2016-313589 10.1016/j.bpg.2013.06.008 10.1136/gutjnl-2012-304269 10.3748/wjg.v19.i39.6523 10.1097/MD.0000000000004089 10.1016/j.kint.2018.04.011 10.1053/j.gastro.2017.01.031 10.1016/j.cgh.2022.06.003 10.1038/s41598-020-62795-1 10.1001/jama.2020.21360 10.1111/nmo.14022 10.1016/S0140-6736(20)30752-2 10.1016/S2468-1253(19)30408-X |
ContentType | Journal Article |
Copyright | 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023 |
Copyright_xml | – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T2 7X7 7XB 88E 8C1 8FE 8FG 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA AN0 ATCPS AZQEC BENPR BGLVJ BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. L6V M0S M1P M7S PATMY PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY 7X8 5PM DOA |
DOI | 10.1186/s12889-023-15272-z |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland British Nursing Database Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Engineering Collection Health & Medical Collection (Alumni) Medical Database Engineering Database (ProQuest) Environmental Science Database (ProQuest) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Collection ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection ProQuest Engineering Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Engineering Database ProQuest Public Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Environmental Science Collection ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Materials Science & Engineering Collection Environmental Science Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) (Open Access) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1471-2458 |
EndPage | 13 |
ExternalDocumentID | oai_doaj_org_article_2dafb15afc2b4c54b730c798349c3897 PMC10053627 A743449237 36978027 10_1186_s12889_023_15272_z |
Genre | Journal Article |
GeographicLocations | China Southeast Asia Asia United States--US Brazil East Asia Paraguay North America Central Europe Oceania Latin America North Korea |
GeographicLocations_xml | – name: China – name: Asia – name: North Korea – name: East Asia – name: Latin America – name: Southeast Asia – name: Paraguay – name: Central Europe – name: Oceania – name: North America – name: United States--US – name: Brazil |
GroupedDBID | --- 0R~ 23N 2WC 2XV 44B 53G 5VS 6J9 6PF 7X7 7XC 88E 8C1 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABJCF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AN0 AOIJS ATCPS BAPOH BAWUL BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BNQBC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR INH INR ITC KQ8 L6V M1P M48 M7S M~E O5R O5S OK1 OVT P2P PATMY PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7T2 7XB 8FK AZQEC C1K DWQXO GNUQQ K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c564t-ede07a0ff18e09835846cf0276e7a08cad7627416b1b556ef7157fb15bd6d2763 |
IEDL.DBID | M48 |
ISSN | 1471-2458 |
IngestDate | Wed Aug 27 01:32:37 EDT 2025 Thu Aug 21 18:37:49 EDT 2025 Fri Jul 11 02:39:35 EDT 2025 Fri Jul 25 10:43:19 EDT 2025 Tue Jun 17 21:31:59 EDT 2025 Tue Jun 10 20:23:02 EDT 2025 Wed Feb 19 02:24:30 EST 2025 Thu Apr 24 23:11:51 EDT 2025 Tue Jul 01 00:56:49 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Age-standardized rate Gastro-esophageal reflux disease Epidemiology Global burden disease |
Language | English |
License | 2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c564t-ede07a0ff18e09835846cf0276e7a08cad7627416b1b556ef7157fb15bd6d2763 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12889-023-15272-z |
PMID | 36978027 |
PQID | 2803005186 |
PQPubID | 44782 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_2dafb15afc2b4c54b730c798349c3897 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10053627 proquest_miscellaneous_2792502243 proquest_journals_2803005186 gale_infotracmisc_A743449237 gale_infotracacademiconefile_A743449237 pubmed_primary_36978027 crossref_citationtrail_10_1186_s12889_023_15272_z crossref_primary_10_1186_s12889_023_15272_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-03-29 |
PublicationDateYYYYMMDD | 2023-03-29 |
PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-29 day: 29 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC public health |
PublicationTitleAlternate | BMC Public Health |
PublicationYear | 2023 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | A Ruigómez (15272_CR21) 2010; 45 LH Eusebi (15272_CR4) 2018; 67 Collaborators GBDG-oRD (15272_CR15) 2020; 5 J Maret-Ouda (15272_CR7) 2020; 324 HB El-Serag (15272_CR13) 2014; 63 Collaborators GBDRF (15272_CR17) 2020; 396 HN Khan (15272_CR10) 2018; 30 A Ustaoglu (15272_CR2) 2020; 32 ZH You (15272_CR8) 2015; 26 CH Chen (15272_CR11) 2016; 95 H Saber (15272_CR5) 2012; 6 J Ronkainen (15272_CR12) 2013; 27 GBD Diseases (15272_CR19) 2020; 396 R Fass (15272_CR1) 2021; 7 Y Xie (15272_CR16) 2018; 94 VR Muthusamy (15272_CR22) 2022; 20 JS Nirwan (15272_CR14) 2020; 10 A Altomare (15272_CR6) 2013; 19 DE Freedberg (15272_CR24) 2017; 152 C Fitzmaurice (15272_CR18) 2019; 5 DA Katzka (15272_CR23) 2020; 371 P Moayyedi (15272_CR3) 2006; 367 SY Kim (15272_CR9) 2019; 9 E Ness-Jensen (15272_CR20) 2017; 31 |
References_xml | – volume: 26 start-page: 534 issue: 7 year: 2015 ident: 15272_CR8 publication-title: Eur J Intern Med doi: 10.1016/j.ejim.2015.05.005 – volume: 5 start-page: 1749 issue: 12 year: 2019 ident: 15272_CR18 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.2996 – volume: 9 start-page: 357 issue: 4 year: 2019 ident: 15272_CR9 publication-title: Int Forum Allergy Rhinol doi: 10.1002/alr.22259 – volume: 396 start-page: 1204 issue: 10258 year: 2020 ident: 15272_CR19 publication-title: Lancet doi: 10.1016/S0140-6736(20)30925-9 – volume: 45 start-page: 139 issue: 2 year: 2010 ident: 15272_CR21 publication-title: Scand J Gastroenterol doi: 10.3109/00365520903428606 – volume: 367 start-page: 2086 issue: 9528 year: 2006 ident: 15272_CR3 publication-title: Lancet doi: 10.1016/S0140-6736(06)68932-0 – volume: 30 start-page: 64 issue: 1 year: 2018 ident: 15272_CR10 publication-title: J Ayub Med Coll, Abbottabad: JAMC – volume: 7 start-page: 55 issue: 1 year: 2021 ident: 15272_CR1 publication-title: Nat Rev Dis Primers doi: 10.1038/s41572-021-00287-w – volume: 6 start-page: 121 year: 2012 ident: 15272_CR5 publication-title: Open Respir Med J doi: 10.2174/1874306401206010121 – volume: 31 start-page: 501 issue: 5 year: 2017 ident: 15272_CR20 publication-title: Best Pract Res Clin Gastroenterol doi: 10.1016/j.bpg.2017.09.004 – volume: 67 start-page: 430 issue: 3 year: 2018 ident: 15272_CR4 publication-title: Gut doi: 10.1136/gutjnl-2016-313589 – volume: 27 start-page: 325 issue: 3 year: 2013 ident: 15272_CR12 publication-title: Best Pract Res Clin Gastroenterol doi: 10.1016/j.bpg.2013.06.008 – volume: 63 start-page: 871 issue: 6 year: 2014 ident: 15272_CR13 publication-title: Gut doi: 10.1136/gutjnl-2012-304269 – volume: 19 start-page: 6523 issue: 39 year: 2013 ident: 15272_CR6 publication-title: World J Gastroenterol doi: 10.3748/wjg.v19.i39.6523 – volume: 95 start-page: e4089 issue: 27 year: 2016 ident: 15272_CR11 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000004089 – volume: 94 start-page: 567 issue: 3 year: 2018 ident: 15272_CR16 publication-title: Kidney Int doi: 10.1016/j.kint.2018.04.011 – volume: 152 start-page: 706 issue: 4 year: 2017 ident: 15272_CR24 publication-title: Gastroenterol doi: 10.1053/j.gastro.2017.01.031 – volume: 20 start-page: 2696 issue: 12 year: 2022 ident: 15272_CR22 publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2022.06.003 – volume: 10 start-page: 5814 issue: 1 year: 2020 ident: 15272_CR14 publication-title: Sci Rep doi: 10.1038/s41598-020-62795-1 – volume: 324 start-page: 2536 issue: 24 year: 2020 ident: 15272_CR7 publication-title: JAMA doi: 10.1001/jama.2020.21360 – volume: 371 start-page: m3786 year: 2020 ident: 15272_CR23 publication-title: BMJ (Clinical Research ed) – volume: 32 start-page: e14022 issue: 12 year: 2020 ident: 15272_CR2 publication-title: Neurogastroenterol Motil J Eur Gastrointest Motil Soc doi: 10.1111/nmo.14022 – volume: 396 start-page: 1223 issue: 10258 year: 2020 ident: 15272_CR17 publication-title: Lancet doi: 10.1016/S0140-6736(20)30752-2 – volume: 5 start-page: 561 issue: 6 year: 2020 ident: 15272_CR15 publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(19)30408-X |
SSID | ssj0017852 |
Score | 2.545568 |
Snippet | For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.
The burden of GORD between... Introduction For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. Methods The... For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019. The burden of GORD between... IntroductionFor effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.MethodsThe... For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.INTRODUCTIONFor effective... Abstract Introduction For effective preventive strategies against GORD (gastro-esophageal reflux disease), we assessed the GORD burden from 1990 to 2019.... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 582 |
SubjectTerms | Age Age factors in disease Age-standardized rate Analysis Care and treatment Diagnosis Disease Epidemiology Esophagus Estimates Gastro-esophageal reflux disease Gastroesophageal reflux Gastroesophageal Reflux - epidemiology Geographical distribution Geographical locations Global burden disease Global Burden of Disease Global Health High income Humans Incidence Population Prevalence Public health Quality-Adjusted Life Years Regions Risk factors Trends World population |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_SkyDit6tVRhA86NL9yNd6q2Ipgp4s9BaSbKKFsk_69oH05P_gzT_Pv8SZZPf1LYJevCaTbJKZzEw2md8w9pw7bdFshzLS_T9dFJVWKVXiedl12nstNQUKf_goj0_4-1NxupPqi96EZXjgvHAHTW-jq4WNvnHcC-5QJL3qdMs7j8Y2xZGjzZsPU9P9gdKimUNktDxYoxamp0FNW1Ia16a8XJihhNb_p07eMUrLB5M7FujoFrs5uY5wmId8m10Lwx12I_93gxxOdJf9zHEJsIrw2a7Hi1WgPAWoNLAljuJ88w2mOxk4G6CpOKRsEXRgBjv0MBJSIwGHhPUrqNGI_Pr-A6139xosXKE-I2nGMgH0eQF9SMi5A-Dq6_NXEn4tUBf32MnRu09vj8sp_0LpheRjGfpQKVvFWOtQ4YqTr-KRp0oGLNbe9ipl7pGudkLIEFUtFDHL9bJHqvY-2xtWQ3jIIPai66LFfmzHK-t064WTMapWxL7VfcHqmR3GT-DklCPj3KRDipYms9AgC01iobks2Mttm68ZmuOv1G-Iy1tKgtVOBShsZhI28y9hK9gLkhFDmx-H5-0Uw4CTJBgtc4j-GCfIO6TcX1DipvXL6lnKzKQ01oYShZGS1LJgz7bV1JIewg1htUEa1aHTin5XW7AHWSi3U2olwUk12LleiOtizsua4exLghSvSRkjMx_9j1V6zK43tNUqyhK4z_bGi014gq7b6J6mXfobm75AOw priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LaxUxFA5aN4KIb6dWiSC40KHzymPcSBWvRdCVhe5CkklqoczUO3OhdOV_cOfP85d4TiYzt4PQ7eQkk3BOzjl5fR8hryojNYRtl3o8_8eDolQLIVJYL5taWiu5xIfCX7_xw6PqyzE7jhtufbxWOfnE4KibzuIe-T6yKKEFSf7-_GeKrFF4uhopNG6SWzlEGrzSJVef51MEIVkxPZSRfL8HX4wXhIoyRTLXIr1cBKOA2f-_Z74SmpbXJq_EodU9cjcmkPRg1Ph9csO1D8idcfeNjo-KHpI_4-sE2nl6ovth3TlkKwDXATWhF2ebCxpPZuhpS4usooEzApfNVLcNHRCvEeFDXP-W5hBK_v76DTG8fkc13WI_g-iIaEIh86WQSdKRQYBu_z79JaDYUmziETlaffr-8TCNLAypZbwaUte4TOjM-1y6rIaEDTIWC5oV3MFnaXUjAn8PN7lhjDsvcia8yZlpeANS5WOy03ate0qob1hdew3t6LrKtJGlZYZ7L0rmm1I2CckndSgbIcqRKeNMhaWK5GpUoQIVqqBCdZmQN3Od8xGg41rpD6jlWRLBtcOHbn2i4lxVRaOx_9rbwlSWVQa8oBUw9Kq2kN-JhLxGG1HoAqB7VseXDDBIBNNSB5CVVQh8B5J7C0mYunZZPFmZiq6jV1tDT8jLuRhr4nW41nUbkBE1pK6QfZUJeTIa5TykkiOoVAGNy4W5Lsa8LGlPfwRg8RxdMihz9_p-PSO3C5xEGbIA7pGdYb1xzyE1G8yLMP_-Ac5vN4U priority: 102 providerName: ProQuest |
Title | Burden of gastroesophageal reflux disease in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of disease study 2019 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36978027 https://www.proquest.com/docview/2803005186 https://www.proquest.com/docview/2792502243 https://pubmed.ncbi.nlm.nih.gov/PMC10053627 https://doaj.org/article/2dafb15afc2b4c54b730c798349c3897 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA69vAgi3l2tSwTBBx2dS24jiHRL1yK0SHGh-BKSTFILy6zuBWp_iT_XczIzux0sfcnD5CSTzMk5OZkk30fIa2aVgWnbJwH3_3GjKDFSygTWy7ZUzimh8KLw8Yk4mrCvZ_xsi3R0R-0HXNy4tEM-qcl8-v7y95_PYPCfosEr8WEBPhYP_uRFgiSteXK1TXZhZpLIaHDMNrsKUkUGngwccpIzrrpLNDfW0ZuoIp7__1772rTVP1J5bY4a3yf32uCS7jej4QHZ8vVDcrf5M0ebC0ePyN_m5gKdBXpuFsv5zCOTAbgVKAmtmK4uabtrQy9qmqeMRj4JXFJTU1d0iViOCC3iF-9oBtMMmEBWfqSGblChQbDBOqEQE1OIMWnDLUA37-7eEfFtKVbxmEzGh98PjpKWnyFxXLBl4iufSpOGkCmflhDKQSzjQOdSeHisnKlkZPYRNrOcCx9kxmWwGbeVqECqeEJ26lntnxEaKl6WwUA9pmSpsapw3IoQZMFDVahqQLJOGdq14OXIoTHVcRGjhG4UqEGBOipQXw3I23WZXw10x63SI9TxWhJht-OD2fxct1as88pg-01wuWWOMwv-0UnoOisdRH5yQN7gCNE4XKF5zrR3HKCTCLOl9yFeYwiJB5J7PUkwatfP7saY7mxCI5EYOlElBuTVOhtL4kG52s9WICNLCGohLisG5GkzJNddKgTCTeVQueoN1l6f-zn1xc8IOZ6hswZlPr-92S_InRxNKEV-wD2ys5yv_EsI2pZ2SLblmYRUHWSYjr8Mye7o8OTb6TD-BhlGS4X0dPTjHwXAQRc |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtUwELVKWYCEEG9uKWAkEAuImpcfQUKoPC639LFqpe5c27FLpSpp70NAV_wDOz6Cj-JLmHGSexshdddtMnZszXhmHHvOIeR5bqSGsO0ij-f_eFAUaSFEBPtlU0hrJZdYKLy9w0d7-Zd9tr9E_nS1MHitsvOJwVGXtcV_5GvIooQWJPm7k9MIWaPwdLWj0GjMYtP9-AZbtsnbjY-g3xdpOvy0-2EUtawCkWU8n0audLHQsfeJdHEBCQhEYAsjFdzBY2l1KQIfDTeJYYw7LxImvEmYKXkJUhn0e4VczTOI5FiZPvw8P7UQkqVdYY7kaxPw_XghKc0iJI9No7Ne8AscAf9HgnOhsH9N81zcG94iN9uEla43FnabLLnqDrnR_O2jTRHTXfK7qYagtaeHejId1w7ZEcBVQUsYxfHsO21PguhRRdM4p4GjArfpVFclnSI-JMKVuMlrmkDo-vvzF-QMxRuq6QJrGkQbBBUKmTaFzJU2jAV08fXuKwE1l2IX98jepejnPlmu6so9JNSXrCi8hn50kcfayMwyw70XGfNlJssBSTp1KNtCoiMzx7EKWyPJVaNCBSpUQYXqbEBezducNIAgF0q_Ry3PJRHMOzyox4eq9Q0qLTWOX3ubmtyy3IDXtQKmnhcW8kkxIC_RRhS6HBie1W3lBEwSwbvUOmSBOQLtgeRqTxJche2_7qxMta5qohYLa0CezV9jS7x-V7l6BjKigFQZsr1sQB40RjmfUsYRxCqFzmXPXHtz7r-pjr4GIPMEQwAoc-XicT0l10a721tqa2Nn8xG5nuKCCrcAV8nydDxzjyEtnJonYS1ScnDZi_8fsCdz5w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Burden+of+gastroesophageal+reflux+disease+in+204+countries+and+territories%2C+1990-2019%3A+a+systematic+analysis+for+the+Global+Burden+of+disease+study+2019&rft.jtitle=BMC+public+health&rft.au=Li%2C+Na&rft.au=Yang%2C+Wan-Li&rft.au=Cai%2C+Mei-Hong&rft.au=Chen%2C+Xiang&rft.date=2023-03-29&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2458&rft.eissn=1471-2458&rft.volume=23&rft.issue=1&rft_id=info:doi/10.1186%2Fs12889-023-15272-z&rft.externalDocID=A743449237 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon |